Back to search

Article

One- or two-day intervals in conditioning regimens for allo-HCT affect chronic graft-versus-host disease, but not other clinical outcomes

2022-02-07

Abstract excerpt

Background. One- or two-day intervals are generally inserted into scheduled conditioning regimens for allogeneic hematopoietic cell transplantation (HCT), primarily due to various social circumstances, such as unexpected natural adversities, abrupt deterioration of patient health, and delays in graft source arrival. We compared the clinical outcomes of patients with interrupted conditioning to those with ordinaril...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
05813951-dd8d-5f2b-9775-bf804e075a7f
DOI
10.22541/au.164425577.76527926/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
One- or two-day intervals in conditioning regimens for allo-HCT affect chronic graft-versus-host disease, but not other clinical outcomesDOI 10.22541/au.164425577.76527926/v1
Allogeneic Hematopoietic Cell Transplantation in the Outpatient SettingSemantic proximity
Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center StudySemantic proximity
Acute and chronic Graft-versus-host disease after hematopoietic stem cell transplantationSemantic proximity
Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors before and after Allogeneic TransplantationSemantic proximity
Long-term outcomes and GVHD in patients receiving hematopoietic cell transplants abroad: A 14-year UAE multi-center cohortSemantic proximity
Long‐term outcome of 2‐year survivors after allogeneic hematopoietic cell transplantation for acute leukemiaSemantic proximity
Venetoclax and azacitidine compared with intensive chemotherapy for adverse-risk acute myeloid leukemia patients receiving allogeneic hematopoietic stem cell transplantation in first complete remission: a multicenter study of TROPHY group.Semantic proximity
TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donorsSemantic proximity
Acute GVHD after allogeneic hematopoietic transplantation affects early marrow reconstitution and speed of engraftmentSemantic proximity
Outcomes among Patients with Recurrent High-Risk Hematologic Malignancies after Allogeneic Hematopoietic Cell TransplantationSemantic proximity
Potent graft-versus-leukemia effect after reduced-intensity allogeneic SCT for intermediate-risk AML with FLT3-ITD or wild-type NPM1 and CEBPA without FLT3-ITD.Semantic proximity
Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplantSemantic proximity
Select a neighboring publication to make it the new centre.